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Antidiabetic activityAbstract Basically ﬂavonoids are naturally occurring phenolic compounds that are distributed in
plants. They contain wide range of biological activity and lot of research has been carried out on
their potential role in treating diabetes and other diseases. Most importantly the ﬂavonoids and
their related natural compounds are known to encompass antidiabetic potential, demonstrated in
various animal models. Such beneﬁcial ﬂavonoids are less utilized on account of its deprived solu-
bility, decreased bioavailability; ﬁrst pass metabolism and intestinal degradation. However, ﬂavo-
noids are capable of improving, stabilizing and long sustaining the insulin secretion, human islets
and pancreatic cell respectively. In this article we propose, remarkable antidiabetic activity of ﬂavo-
noids as well as few approaches on nanoparticulate systems in diabetes induced animal models. The
proposed nanoparticulate system of ﬂavonoids is projected to improve the solubility, bioavailabil-
ity, by passing the ﬁrst pass metabolism and decreasing susceptibility to intestinal environment as
compared to pure ﬂavonoid isolates. Further, this hypothesis exempliﬁes to enhance the efﬁcacy of
ﬂavonoids in a novel way of antidiabetic treatment.
Crown Copyright ª 2013 Tehran University of Medical Sciences. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.Introduction
The most ubiquitous part of plant constituents are ﬂavonoids,
so far about 8000 varieties of ﬂavonoids have been identiﬁed
[1]. The ﬂavonoids are bioactive phenols with low molecular
weight and play a major role in the cell synthesis [2–5].Flavonoids are highly present in fruits, vegetables, nuts, seeds,
stem, ﬂowers tea etc., [6]. As for as diabetes mellitus is concern,
ﬂavonoids play a vital role in all aspects and its mechanism is
well known [7].
Diabetes is a metabolic disorder leads to hyperglycemia and
hindrance in carbohydrate, protein and fat metabolisms result-
ing in deprived insulin proﬁle [8]. The effective control ofY-NC-ND license.
Table 1 Remarkable endeavors to surmount the limitations of various ﬂavonoidal nanoparticulate system.
S. No Endeavors Flavonoids Result Refs.
1 b-cyclodextrin nanoparticles of propolis
extract
Kaempferol, rutin, quercetin, apigenin,
acacetin, chrysin
Lower release pattern of ﬂavonoids from
b-cyclodextrin cavity
[11]
2 Enhancement of dissolution of
kaempferol nanoparticles
Kaempferol Improved solubility of kaempferol [12]
3 Biodegradable poly-D,L-lactide (PLA)
nanoparticles of quercetin
Quercetin Biphasic release of nanoparticles followed
by sustained slow release
[13]
4 Stevioside pluronic-F-68 copolymer PLA-
nanoparticles
Stevioside (non caloric sweetener) Increased intestinal absorption,
biocompatibility and bioavailability and
caused a controlled release
[14]
5 PLGA Nanohydrogel matrix for oral
delivery of ﬂavonoid
Silymarin Enhanced dissolution and Bioavailability [15]
Table 2 Remarkable endeavors to surmount the limitations of various ﬂavonoidal isolates in animal models.
S. No. Endeavors Flavonoids Result Refs.
1 Averrhoa carambola isolated









2 Acacia auriculiformis poly
ﬂavonoids on antidiabetic factor
Gallic acid, caﬀeic acid, catechin,
rutin, quercetin, myricetin and
kaempferol
Signiﬁcant suppression on a-
amylase and a-glucosidase.
[17]





observed in alloxan induced
diabetic rats
[18]
4 Icariin in diabetic rats on
mitochondrial oxidative stress
Icariin Improvement in overall
complication of diabetes in
steptozotocin induced rats
[19]
5 Kaempferitrin on glucose uptake
on skeletal muscles




6 Isolates from Euonymus alatus in
glucose uptake
Kaempferol and quercetin Potential ameliorated
hyperglycemia observed, due to
glucose uptake in mature 3T3-L1
adipocytes
[21]
7 An isolate exposure on chronic
hyperglycemic b-cell




8 Flavonoid isolate as
insulinomimetic on glycemia and
glucose uptake
Kaempferitrin Lowering blood glucose level and
14C uptake of glucose in
peripheral muscles of rat
[23]
9 Inhibition of intestinal and renal
Na-glucose cotransporter
Naringenin Inhibition of intestinal glucose
uptake and renal glucose
reabsorption was observed
[24]
10 Combined eﬀect of ﬂavonoid in
type 2 diabetic rat
Naringin and hesperidin Synergistic insulin releasing eﬀect [25]
11 Antidiabetic activity of isolate in
normoglycemic rats
Naringenin Diminishing the carbohydrate
absorption from intestine and
reduced post prandial glucose
levels
[26]
12 Enhancement of bioavailability and
anti-diabetic eﬃcacy
Berberine Increased bioavailability and a
promising alternative for diabetes therapy
[27]
2 S. Mohan, L. Nandhakumarblood glucose level is an effective strategy in reducing clinical
complications of diabetes mellitus remarkably. Besides optimal
control of blood glucose level alone, could not preventcomplications and it promotes to hypothesize an alternative
treatment approaches essentiality [9]. Even though there is
no cure for diabetes, the pharmacological and non-pharmaco-
Figure 1 Flavonoids function in diabetes mellitus.
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proved the quality of life to certain extent. However, a compli-
cation pertaining to micro and macro-vascular set up of the
body remains imperative. The role ﬂavonoids are quite impor-
tant in ﬁghting with the complications of diabetes mellitus
than any other method of treatment [10].
In recent years various approaches have been made to
utilize the ﬂavonoids in animal model to by incorporating
few novel methods to improve its antidiabetic property, they
are categorized in Tables 1 and 2 [11–27]. Nevertheless, in
this context we propose few nanoparticulate systems in ani-
mal models and other signiﬁcant role as extracts are com-
piled and given.Hypotheses
We propose ﬂavonoid in nanoparticulate system like ﬂavo-
noids association with polymers prone to show enhanced
properties for the purpose it is intended to it (Fig. 1).
We suggest the following(1) Flavonoids have solid potential to serve as better alter-
native for diabetic treatment. Lack of safety is a main
concern in using current system for treating diabetes
and more prone to have serious side effects. Substantial
evidences are there to prove the antidiabetic activity for
even to single ﬂavonoidal component.
(2) One of the problem associated with utilizing the ﬂavo-
noids as alternative approach is that they are poorly sol-
uble candidates. Improving the solubility of ﬂavonoids
would beneﬁt the treatment protocol for diabetes as an
alternative approach.
(3) Flavonoids are the promising alternative for diabetes
and its associated complications. However, effective
control of not only keeping the blood glucose level opti-
mum will provide better results, but compromising con-
tinued damage of human islets as well as stabilizing the
cellular components is more essential for effective dia-
betic management.
(4) Adopting novel methods to improve the solubility of
ﬂavonoids would account for enhanced bioavailability
of the fraction and dose reduction initiative. Various
4 S. Mohan, L. Nandhakumarmethods are there to improve the component solubility.
Further, novel techniques incorporation leads to
improved utilization of ﬂavonoids.
(5) More relatively the possibility of nanoparticulate system
comprising ﬂavonoids ensures the altered pattern of
release preferably slow release will account for increased
intestinal absorption, thereby the chance of getting
affected from gastric enzymes are prevented.
(6) Profound biodegradable and biocompatible polymers
are the viable option to encounter the problem associ-
ated with solubility. As it improves the antidiabetic
property of ﬂavonoids as compared with pure isolate
of ﬂavonoids.
(7) Nanoparticulate system of ﬂavonoids will produce bet-
ter results if the component of same ﬂavonoids is used
in increased dose, if tested in animal models. The side
effect of current diabetic treatment associated with the
damaging of signaling pathways and cellular networks
can better be prevented with ﬂavonoid nanoparticulate
system.
Evaluation of hypotheses
The propositions are conﬁrmed by following studies
(1) We put forward to evaluate the ﬂavonoid nanoparticu-
late system to that of pure drug. This is to evaluate
and conﬁrm that the suggested nanoparticulate system
provide enhanced solubility and bioavailability over
the ﬂavonoid administration as such.
(2) Biocompatibility of ﬂavonoids and selected polymers are
done to show that there is no interaction between
ﬂavonoid and polymer. It is proposed to conﬁrm by
Fourier Transmission Infrared Spectroscopy (FTIR),
Differential Scanning Colorimetry (DSC) etc. to ensure
the possible interaction between the intra ﬂavonoid
nanoparticulate systems.
(3) We propose to conﬁrm the formation of nanoparticulate
system by any of the established technique like nanopre-
cipitation, solvent evaporation method etc. Steps must be
taken to prove the efﬁcacy of the particulate system as it is
superior in antidiabetic property as compared to pure
component. This is to conﬁrm the formation of nanopar-
ticulates with optimum drug loading and drug entrap-
ment potential by suitable factorial designing.
(4) We suggest to utilize various groups of animal models are to
evaluate the antdiabetic property of the prepared
nanoparticles. We propose suitable analytical method evalu-
ate the blood glucose level at various intervals. It is to ensure
the bioavailability of nanoparticulates with pure drug.
(5) We propose to conﬁrm the surface morphology and
dimension of the prepared particulate system by Trans-
mission ElectronMicroscopy (TEM), Scanning Electron
Microscopy (SEM) and particle size analysis by Zetasizer.
This is done to ensure the size distribution and surface
characteristics, which also determines the solubility of
the prepared nanoparticulates.
(6) Propositions are implied to ensure the dissolution of the
nanoparticulate system by using suitable USP model
dissolution apparatus. Samples must be withdrawn atsuitable intervals and ﬂavonoid contents are determined
at each interval. This study is to conﬁrm the release
pattern of the ﬂavonoids from particulate system.
(7) To ensure the stability of the formulation, preparations
are stored at various temperature. This study is to pro-
vide the stability of ﬂavonoid nanoparticulates as com-
pared with the pure component.
(8) We propose to study the cell line uptake of glucose by
ﬂavonoids or insulinomimmetic activity of ﬂavonoids
as nanoparticulates are measured in insulin sensitive
cells. This study is done to ensure the antidiabetic activ-
ity of nanoparticulate ﬂavonoids with that of pure drug.
Discussion
Novel approach to treat diabetes with ﬂavonoid nanoparticu-
late system to enhance the antidiabetic activity on animal mod-
els has been discussed in this article. Diabetes is the wide
spread pandemic disease resulting in increased morbidity and
mortality. The blood glucose level of diabetics can be effec-
tively controlled by utilizing currently available antidiabetic
agents. The FDA approved anti diabetic agents is used for
the therapy to control blood glucose level [28,29]. Incorpora-
tion of natural antidiabetic preparation is given privilege to
make use of it, as it holds less toxicity and negligible side ef-
fects. Almost all the ﬂavonoids having potential for antidia-
betic activity but they are limited in usage on account of
deprived solubility and bioavailability.
Among the well known antidiabetic formulation stevioside
from the leaves of Stevia rebaudiana is reported as antidiabetic
drug [30]. The stevioside regulates the blood glucose concen-
tration by increasing insulin secretion and utilization in rats.
[31–33]. Stevioside is potent antidiabetic agent but less compe-
tent because of less bioavailability, less persistence and degra-
dation in metabolism. To overcome the problem of solubility a
poly (D,L-lactic acid) nanoparticles of stevioside prepared by
nanoprecipitation method [14]. Further nanoencapsulated ste-
vioside of PLA nanoparticles have better bioavailability and
intestinal absorption than stevioside. The combination setarud
with quercetin is proved to be a viable alternative for diabetes
[34]. Based on the above fact we propose polymeric nanopar-
ticles increases the bioavailability than the ﬂavonoid alone
for safer antidiabetic treatment alternative with synergistic ac-
tion. On other hand, role of biological antioxidants like super
oxide dismutase (SOD), catalase (CAT) etc., in recent times for
pancreatic islets isolation and transplantation in animal mod-
els has been very effective [35]. This activity reveals the option
for utilizing plant biomolecules (ﬂavonoids) in transplantation
process involving pancreas with novel technology.
Conclusion
In this context, we propose a novel approach to treat diabetes
with enhanced antidiabetic activity from ﬂavonoid nanopar-
ticulate system. The proposed nanoparticulate systems with
novel biodegradable releasers are to increase the solubility
of ﬂavonoids, which in turn it increases the bioavailability
of the ﬂavonoid component. The proposed system further ex-
pected to prevent ﬂavonoid from ﬁrst pass metabolism and
intestinal absorption in the form of ﬂavonoid nanoparticulate
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have better antidiabetic potential against the isolate of pure
ﬂavonoids.Overview box
First question: What do we already know about this sub-
ject?
Flavonoids are compounds present almost in all fruits
and vegetables. They are responsible for various activities
like antidiabetic, anticancer, anti-inﬂammatory and so on.
Especially, antidiabetic potential properties of these ﬂavo-
noids are limited in use, because of its limited solubility,
bioavailability and subsequent undesirable metabolism
at various sites in the body.Second question: What does your proposed theory add
to the current knowledge available, and what beneﬁts does
it have?
Nanoparticulate ﬂavonoidal system provides a viable
option to overcome the problem associated with solubil-
ity, bioavailability and biocompatibility with various
entrapping systems. With facile analytical tool and
numerous biodegradable agents available, nanoparticu-
late system is an easy word. Such fabricated nanopartic-
ulate system of potential ﬂavonoids would have better
synergistic activity against the non particulates or
isolates.Third question: Among numerous available studies, what
special further study is proposed for the testing of idea?
We suggest evaluating ﬂavonoid nanoparticulate sys-
tem in various animal models for the antidiabetic activity
(insulinomimmetic, stimulation of pancreatic cell and
blood glucose levels). We suggest detailed examination
on release pattern of components from the nanoparticu-
late system by in vitro studies. Comparisons of prepared
system with the pure component of the same ﬂavonoids
are performed in animal models. Incorporation of cell line
study provides detailed behavioral pattern and pathway
of the ﬂavonoids.Acknowledgement
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